{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:15:35Z","timestamp":1792419335504,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Fatty liver is a disease caused by the accumulation of fat in the liver. It is one of the major risk factors for developing cirrhosis and hepatocellular carcinoma. Saudi Arabia is one of the most prevalent countries in diabetes and obesity; the overall prevalence of diabetes is 23.7% and obesity is 35.6%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To study the correlation between fatty liver finding on abdominal ultrasound (US) and their clinical and biochemical profile including BMI, blood glucose level, lipid profile, liver function tests, and blood pressure in both group lean and obese patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Cross-sectional study of 346 fatty liver ultrasound-proven patients were enrolled in the study from January to May 2016 in King Saud Hospital- Qassim, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Mean age of the participants was 50.3 years. Female participants were 55% of the cohort. Participants were divided based on their BMI: BMI &lt;25 (lean), BMI of 25\u201330 (overweight and mild obesity), and BMI &gt;30 (morbid obesity). We found that cholesterol (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.007) and low-density lipoprotein (LDL) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015) were higher in lean compared to others (5 and 3.1), respectively. Gamma-glutamyl transferase (GGT) was higher in mildly obese patients (113.2) and ALT, which was higher in lean patients (60.4). In addition, 34.5% of the overall patients had Diabetes Mellitus (DM). We found that HbA1c was lower in lean (7.3) compared to morbidly obese patients (7.6). Platelets counts were higher in morbidly obese patients (278) compared to other groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>High cholesterol and LDL strongly correlated with lean fatty liver patients. There was a significant relationship between the female gender and the risk of development of fatty liver. However, liver enzymes were within the normal range, except GGT, which was higher in all the groups, with the highest value in mildly obese patients. Therefore, they are not sensitive for diagnosing fatty liver patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_185_21","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T10:04:42Z","timestamp":1633428282000},"page":"3381-3386","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center"],"prefix":"10.4103","volume":"10","author":[{"given":"Khalid A.","family":"Alsuhaibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris S.","family":"Althunayyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Alsudays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad A.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badr M.","family":"Aljarallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20240828","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.3748\/wjg.v20.i24.7718","article-title":"Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease","volume":"20","author":"Hu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R2-38-20240828","first-page":"841","article-title":"Use of BARD scoring system in non-alcoholic fatty liver disease patients and its correlation with ultrasonographic grading in Gizan, Saudi Arabia","volume":"15","author":"Ageely","year":"2016","journal-title":"Trop J Pharm Rs"},{"key":"R3-38-20240828","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/hepr.12333","article-title":"Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges","volume":"45","author":"Hashimoto","year":"2015","journal-title":"Hepatol Res"},{"key":"R4-38-20240828","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"R5-38-20240828","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/1319-3767.153812","article-title":"Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis","volume":"21","author":"AlShaalan","year":"2015","journal-title":"Saudi J Gastroenterol"},{"key":"R6-38-20240828","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"},{"key":"R7-38-20240828","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2221-1691(13)60177-X","article-title":"Comparison of lipid profile in different grades of non-alcoholic fatty liver disease diagnosed on ultrasound","volume":"3","author":"Mahaling","year":"2013","journal-title":"Asian Pac J Trop Biomed"},{"key":"R8-38-20240828","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jgh.12334","article-title":"Prevalence and risk factors of fatty liver disease in young and middle-aged population: One center study in Southwestern China","volume":"29","author":"Xiao","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-38-20240828","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1589\/jpts.26.1865","article-title":"Analysis of biochemical markers related to fatty liver patients","volume":"26","author":"Cho","year":"2014","journal-title":"J Phys Ther Sci"},{"key":"R10-38-20240828","first-page":"1295","article-title":"Non-alcoholic fatty liver disease-clinical and histopathological aspects","volume":"57","author":"Popescu","year":"2016","journal-title":"Rom J Morphol Embryol"},{"key":"R11-38-20240828","doi-asserted-by":"crossref","first-page":"e0172921","DOI":"10.1371\/journal.pone.0172921","article-title":"Characterisation of liver fat in the UK Biobank cohort","volume":"12","author":"Wilman","year":"2017","journal-title":"PLoS One"},{"key":"R12-38-20240828","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome-a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"R13-38-20240828","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.crohns.2012.10.015","article-title":"Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"7","author":"Sourianarayanane","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R14-38-20240828","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden \u2013 Saudi Arabia and United Arab Emirates, 2017\u20132030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"R15-38-20240828","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon","year":"2014","journal-title":"Hepatology"},{"key":"R16-38-20240828","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11605-014-2678-y","article-title":"Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis","volume":"19","author":"Taitano","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"R18-38-20240828","doi-asserted-by":"crossref","first-page":"872","DOI":"10.9734\/BJMMR\/2015\/13077","article-title":"Nonalcoholic Fatty Liver Disease (NAFLD) in Saudi Patients with T2DM in Jazan region: Prevalence and associated factors","volume":"5","author":"Elmakki","year":"2015","journal-title":"Br J Med Med Res"},{"key":"R19-38-20240828","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12887-017-0867-z","article-title":"Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity","volume":"17","author":"Jimenez-Rivera","year":"2017","journal-title":"BMC Pediatr"},{"key":"R20-38-20240828","first-page":"29","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD); Frequency in Diabetes Mellitus (Type II) patients and non diabetic group at Shalamar Medical and Dental College, Lahore","volume":"23","author":"Alavi","year":"2016","journal-title":"Professional Med J"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_185_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:07:11Z","timestamp":1787166431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_185_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_185_21","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}